Home

pap Tapasztalt személy Megérkezés win cannabinoid Működtető kérés Zsonglőrködés

Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and  IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology &  Translational Science
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology & Translational Science

Francesca Telese on LinkedIn: Our latest work on the role of cannabinoids  in inflammation: The…
Francesca Telese on LinkedIn: Our latest work on the role of cannabinoids in inflammation: The…

Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human  osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1

The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell  Lines | Anticancer Research
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research

The cannabinoid receptor agonist WIN 55,212-2 (WIN) (( R)... | Download  Scientific Diagram
The cannabinoid receptor agonist WIN 55,212-2 (WIN) (( R)... | Download Scientific Diagram

Win 55212-2 | C27H26N2O3 | CID 5311501 - PubChem
Win 55212-2 | C27H26N2O3 | CID 5311501 - PubChem

Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development |  News & Announcements | Cayman Chemical
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical

WIN 55,212-2 mesylate | ≥99%(HPLC) | CB receptor agonist | AdooQ®
WIN 55,212-2 mesylate | ≥99%(HPLC) | CB receptor agonist | AdooQ®

Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human  osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1

WIN 55,212-2 - Wikipedia
WIN 55,212-2 - Wikipedia

Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation  Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult  Offspring of Both Sexes | eNeuro
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes | eNeuro

WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris  Bioscience
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience

Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death  of oral and pancreatic stem-like/poorly differentiated tumor cells -  ScienceDirect
Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells - ScienceDirect

Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development |  News & Announcements | Cayman Chemical
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical

WIN-55212-2 mesylate Supplier | CAS 131543-23-2 | Focus Biomolecules
WIN-55212-2 mesylate Supplier | CAS 131543-23-2 | Focus Biomolecules

What is a cannabinoid? — Why Not THC
What is a cannabinoid? — Why Not THC

The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like  behavior and locomotion in a genetic model of absence seizures in the  elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &
The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &

Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells  Is Phosphatase Dependent | Anticancer Research
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research

Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal  dopaminergic and cannabinoid systems in the rat brain - ScienceDirect
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect

WIN 55,212-2 - an overview | ScienceDirect Topics
WIN 55,212-2 - an overview | ScienceDirect Topics

Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the  innate intestinal immune response | Scientific Reports
Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the innate intestinal immune response | Scientific Reports

Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the  Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by  Tetrahydrocannabivarin
Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin

Chronic, intermittent treatment with a cannabinoid receptor agonist impairs  recognition memory and brain network functional connectivity - Mouro - 2018  - Journal of Neurochemistry - Wiley Online Library
Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity - Mouro - 2018 - Journal of Neurochemistry - Wiley Online Library

Cannabinoid-induced increase of quantal size and enhanced neuromuscular  transmission | Scientific Reports
Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission | Scientific Reports

Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of  N-Methyl-d-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in  Dorsal Root Ganglion Neurons | Journal of Pharmacology and Experimental  Therapeutics
Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-d-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons | Journal of Pharmacology and Experimental Therapeutics